Movement Alert|Docusign Falls 5.07% in Regular Trading, Profit-Taking Follows Strong Q2 Earnings Beat Amid Sector Weakness

Market Focus
Sep 08

On September 8, Docusign fell 5.07% in regular trading, trading at $64.99/share, with turnover of $60.37 million. The decline comes as investors took profits following the company's strong fiscal Q2 earnings release on September 3, which had initially sent shares surging over 9% after hours.

Docusign reported fiscal Q2 revenue of $875.7 million, up 9.4% year-over-year, beating consensus estimates of $867.2 million. Adjusted EPS came in at $1.16, exceeding the $1.09 estimate by 6.4%. The company also raised its full-year revenue guidance to $3.50–$3.51 billion and lifted IAM ARR mix targets to 18%–19%. Despite the beat, multiple analysts noted that shares appear fully valued at current levels. BofA Securities raised its price target to $64 while maintaining an Underperform rating, while RBC, Morgan Stanley, and Piper Sandler raised targets to $70–$75 but kept neutral-equivalent ratings.

Broader Application Software sector weakness amplified selling pressure, with Salesforce.com down 4.59%, Strategy down 2.9%, and Circle Internet down 2.76%, reflecting a risk-off tone across the group.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10